Expected Pain Relief

152 Patients, the largest neurostimulation clinical trial ever conducted among patients with chronic intractable lower limb pain typically resulting from a previous injury, the accurate clinical study, showed that with DRG therapy:3

Pain Relief Statistics

74.2% of DRG patients had pain relief at 12 months.*

* Compared with the Control group
Stimulation Statistics

94.5% of DRG patients did not experience stimulation outside of their primary area of pain at 12 months.*

* Compared with the Control group
Pain Reduction Statistics

DRG patients had an average of 81.4% reduction in their pain at 12 months.

3. Levy, R. & Deer, T. (2015). A prospective, randomized, multi-center controlled clinical trial to assess the safety and efficacy of the Spinal Modulation Axium™ Neurostimulator System in the treatment of chronic pain. Presented at NANS 2015. Description of the Material: Axium™ neurostimulator system (Illustrations from 15320 DRG Patient Brochure (SJM¬AXM¬0915¬0012) Illustrations on Page 11)